Infinimmune vs Ternary Therapeutics
Infinimmune vs Ternary Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Infinimmune is on 60/100 and Ternary Therapeutics on 49/100.
Where each one leads
Infinimmune
- our overall score: 60/100 against 49/100
- agent readiness: 42/100 against 22/100
- domain rating: 20/100 against 6/100
- funding raised: $75.0M against $4.3M
Ternary Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Infinimmune | Ternary Therapeutics |
|---|---|---|
| What it is | Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms. | AI platform for engineering molecular glues to create a new class of medicines. |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech | Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2024 |
| Headquarters | Alameda, United States | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Infinimmune | Ternary Therapeutics |
|---|---|---|
| Employees | 22 | Not published |
| Total funding | $75.0M | $4.3M |
| Latest round | Series A | Seed |
| LinkedIn followers | 4,055 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Infinimmune | Ternary Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 49/100 |
| Traction | 53/100 | 33/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 23/100 | 12/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 6/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Infinimmune | Ternary Therapeutics |
|---|---|---|
| Hosting | Not detected | AWS |
| CDN | Cloudflare | CloudFront |
| CMS | Webflow | Not detected |
| Frameworks | Not detected | Bootstrap |
| Analytics | Google Analytics 4 | Not detected |
Infinimmune vs Ternary Therapeutics: common questions
Which is better, Infinimmune or Ternary Therapeutics?
On our 0-100 score Infinimmune rates higher (60/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Infinimmune and Ternary Therapeutics compare on the numbers?
Infinimmune leads on our overall score (60/100 against 49/100), agent readiness (42/100 against 22/100), domain rating (20/100 against 6/100), funding raised ($75.0M against $4.3M).
Read the full Infinimmune review and pricing or the Ternary Therapeutics review and pricing. You can also browse other Infinimmune alternatives we track.